The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 23, 2025

Filed:

Jul. 20, 2020
Applicants:

Seneca Therapeutics, Inc., Blue Bell, PA (US);

The Trustees of Columbia University IN the City of New York, New York, NY (US);

Inventors:

Vincent R. Racaniello, Scotch Plains, NJ (US);

Amy B. Rosenfeld, New York, NY (US);

Paul L. Hallenbeck, Blue Bell, PA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/768 (2015.01); A61K 31/165 (2006.01); A61K 31/4745 (2006.01); A61K 31/553 (2006.01); A61K 39/395 (2006.01); A61K 45/00 (2006.01); C07K 16/28 (2006.01); C12N 7/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/768 (2013.01); A61K 31/165 (2013.01); A61K 31/4745 (2013.01); A61K 31/553 (2013.01); C07K 16/2866 (2013.01); C12N 7/00 (2013.01); C12N 2770/32032 (2013.01);
Abstract

Provided herein are compositions and methods of using Seneca Valley Virus (SVV) or a derivative thereof and an interferon type I (IFN-I) inhibiting agent comprising an mTOR inhibitor for treating a cancer in a subject. The disclosed methods particularly rely upon the expression level of an ANTXR1 and the expression level of IFN-I in the cancer from the subject. Also provided herein are methods for predicting the efficacy of an SVV treatment comprising IFN-I inhibiting agent.


Find Patent Forward Citations

Loading…